Clinical trial
Pharmacogenetics of Ace Inhibitor-Associated Angioedema:Aim 1
NCT01413542 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacogenetics of Ace Inhibitor-Associated Angioedema:Aim 1
- Lead sponsor
- Vanderbilt University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2011
- Completion date
- July 31, 2014
- Enrollment
- 44 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes type 2, hypertension